Medicure Inc (TSX:MPH)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - MPH

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - MPH

  • Market CapCAD9.380m
  • SymbolTSX:MPH
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINCA58469E4085

Company Profile

Medicure Inc is a specialty pharmaceutical company. It is involved in research, clinical development, and commercialization of human therapeutics for United States hospital market. Its main focus is on sale and marketing of its drug Aggrastat which is a glycoprotein GP IIb/IIIa receptor antagonist, is used for the treatment of acute coronary syndrome including unstable angina. The firm derives the majority of its revenue geographically from the United States.Medicure Inc is in the business of research, clinical development and commercialization of human therapeutics for United States hospital market. It has Marketing and distribution of Aggrastat and Manufacturing and distribution of API segments.

Latest MPH news

Currently there for this company. Visit our news hub for other news .